| Latest Ondine Bio News Headlines |
| Date | Time | Source | |
| 09/05/2008 | 7:36AM | UKREG | Notice of Meeting
Ondine Announces Presentation of Positive Clinical Trial Results at the
American Academy of Periodontology's 94th Annual Meeting
VANCOUVER, Sept. 5 /CNW/ - Ondine Biopharma Corporation (TSX: OBP;
AIM: OBP), a medical technolo
gy company developing photodisinfection-based
products, today announced that a poster... More...>> |
| 08/27/2008 | 7:00AM | UKREG | Ondine FDA Confirmation for PeriowaveTM
Ondine Announces FDA Confirmation of Regulatory Pathway for Periowave(TM)
VANCOUVER, Aug. 27 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company developing photodisinfection-based
products, today announced it has received confirmation from the U.S. Food &
Drug Administration... More...>> |
| 08/14/2008 | 7:00AM | UKREG | Ondine Biopharma Second Quarter Financial Results
Ondine Biopharma Announces Second Quarter 2008 Financial Results
VANCOUVER, Aug. 14 /CNW/ - Ondine Biopharma Corporation (the "Company" or
"Ondine", TSX: OBP; AIM: OBP) a medical technology company developing
photodisinfection based products, today announced its financial results for
the second quarter ended... More...>> |
| 08/07/2008 | 7:00AM | UKREG | Ondine Announces Publication of Positive Results
Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa
Eradication Study
VANCOUVER, Aug. 7 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company developing photodisinfection-based
products, today announced that the results of a study using the Company's
platform... More...>> |
| 08/06/2008 | 7:00AM | UKREG | Ondine to Present at Canaccord Adams 28th Annual Global
Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference
VANCOUVER, Aug. 6 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company developing photodisinfection-based
products, today announced that its Chief Technology Officer, Dr. Nicolas
Loebel, is scheduled... More...>> |
| 07/29/2008 | 2:01AM | UKREG | Statement re license acquisition
Ondine Announces Acquisition of Exclusive License for Gold-Nanoparticle
Photosensitizer
VANCOUVER, July 29 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company developing photodisinfection-based
products, today announced that it has acquired an exclusive license for the
human... More...>> |
| 07/02/2008 | 9:31AM | UKREG | Research Update
Ondine announces Periowave presentation at IADR annual meeting
VANCOUVER, July 2 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company developing photodisinfection-based
products, today announced that data from a study evaluating its Periowave
Photodynamic Disinfection System... More...>> |
| 06/18/2008 | 2:00AM | UKREG | Early Warning Report
Early Warning Report - CEO's ownership interest in Ondine Biopharma
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES/
VANCOUVER, June 17 /CNW/ - On June 13, 2008, Carolyn Cross (the
"Offeror"), President and Chief Executive Officer of Ondine Biopharma
Corporation... More...>> |
| 06/04/2008 | 7:00AM | UKREG | Ondine Photodisinfection Laser Health Canada License
Ondine Receives Health Canada License for Multi-Purpose Photodisinfection
Laser
VANCOUVER, June 4 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP), a medical technology company announces that it has received a Health
Canada license for a next-generation multi-purpose laser system that is
suitable... More...>> |
| 05/29/2008 | 7:00AM | UKREG | Highlights Successful Multi-Centre Gum Disease Trial
Ondine Highlights Successful Multi-Centre Gum Disease Trial Outcomes at
Vancouver Symposium
VANCOUVER, May 29 /CNW/ - Ondine Biopharma Corporation (TSX: OBP;
AIM: OBP), a medical technology company, today announced that it will be
presenting clinical and scientific data on Periowave(TM) at a symposium being
hosted... More...>> |
| 05/27/2008 | 2:00AM | UKREG | Ondine Receives Health Canada License
Ondine Receives Health Canada License for the Treatment of Outer Ear
Infections
VANCOUVER, May 26 /CNW/ - Ondine Biopharma Corporation (TSX: OBP;
AIM: OBP), a medical technology company developing photodisinfection-based
products, today announced it received a Health Canada license for of its
non-antibiotic... More...>> |
| 05/13/2008 | 7:01AM | UKREG | 1st Quarter Results
Ondine Biopharma Announces First Quarter 2008 Financial Results
TORONTO, May 13 /CNW/ - Ondine Biopharma Corporation (the "Company" or
"Ondine", TSX: OBP; AIM: OBP) a medical technology company developing
photodisinfection based products, today announced its financial results for
the first quarter ended March 31... More...>> |
| 05/07/2008 | 7:01AM | UKREG | Announces Successful Outcome from Trial
Ondine Announces Successful Outcome from Periowave(TM) Multi-Center Gum
Disease Trial
VANCOUVER, May 7 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP) today announced outcomes of its Canadian Multi-Center Gum Disease Trial
using the Periowave(TM) photodisinfection system for treatment of chronic
adult... More...>> |
| 04/30/2008 | 2:04AM | UKREG | Publication of Annual Report
Ondine Biopharma Corp
30 April 2008
30 April 2008
Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company")
Publication of Annual Report and Accounts
Ondine Biopharma (AIM & TSX: OBP) announces that its report and accounts for the
year ended December 31, 2007... More...>> |
| 04/03/2008 | 5:51AM | UKREG | Director Transaction
Ondine Biopharma Corp
03 April 2008
April 3, 2008
Ondine Biopharma Corporation
Ondine Biopharma Corporation ("Ondine" or the "Company") today announces the
following transactions by Directors of the Company:
Name Carolyn... More...>> |
| 03/27/2008 | 7:00AM | UKREG | Research Update
Periowave(TM) Gum Disease Treatment Studies to be Presented at AADR Annual
Meeting
VANCOUVER, March 26 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM:
OBP; the "Company"), a medical technology company developing
photodisinfection-based products, today announced that the results of two
studies using the Periowave(TM... More...>> |
| 03/25/2008 | 7:00AM | UKREG | Final Results
Ondine Biopharma Announces 2007 Year End Financial Results
VANCOUVER, March 25 /CNW/ - Ondine Biopharma Corporation (the "Company"
or "Ondine", TSX: OBP; AIM: OBP) a medical technology company developing
photodisinfection based products, today announced its financial results for
the year ended December 31, 2007... More...>> |
| 03/07/2008 | 7:37AM | UKREG | Ondine's Product Showcased at Dental Conference
Ondine's Periowave(TM) Photodisinfection System Showcased at Pacific Dental
Conference in Vancouver BC
VANCOUVER, March 7 /CNW/ - Ondine Biopharma Corporation (TSX: OBP;
AIM: OBP; the "Company"), a medical technology company developing
photodisinfection based products, today announced that its Periowave(TM)
Photodisinfection... More...>> |
| 03/06/2008 | 7:00AM | UKREG | Research Update
Ondine Announces Findings in Photodisinfection Treatment of MRSA to be
Presented at the Society for General Microbiology's 162nd Meeting in Scotland
VANCOUVER, March 6 /CNW/ - Ondine Biopharma Corporation (TSX: OBP;
AIM: OBP; the "Company"), a medical technology company developing
photodisinfection based products... More...>> |
| 12/20/2007 | 7:00AM | UKREG | Regulatory Approval
Ondine Provides Update on FDA Submission Process for its Periowave(TM)
Photodisinfection System
VANCOUVER, Dec. 20 /CNW/ - Ondine Biopharma Corp. (TSX, AIM: OBP) reports
that the CDRH branch of the FDA has reviewed its submission for the
Periowave(TM) photodisinfection system. CDRH has classified the device as
Class... More...>> |